Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IGF-1 in Friedreich's Ataxia - proof-of-concept trial.
Sanz-Gallego I, Torres-Aleman I, Arpa J. Sanz-Gallego I, et al. Among authors: arpa j. Cerebellum Ataxias. 2014 Jul 4;1:10. doi: 10.1186/2053-8871-1-10. eCollection 2014. Cerebellum Ataxias. 2014. PMID: 26331034 Free PMC article.
IGF-1 in autosomal dominant cerebellar ataxia - open-label trial.
Sanz-Gallego I, Rodriguez-de-Rivera FJ, Pulido I, Torres-Aleman I, Arpa J. Sanz-Gallego I, et al. Among authors: arpa j. Cerebellum Ataxias. 2014 Oct 2;1:13. doi: 10.1186/s40673-014-0013-8. eCollection 2014. Cerebellum Ataxias. 2014. PMID: 26331037 Free PMC article.
Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial.
Pandolfo M, Arpa J, Delatycki MB, Le Quan Sang KH, Mariotti C, Munnich A, Sanz-Gallego I, Tai G, Tarnopolsky MA, Taroni F, Spino M, Tricta F. Pandolfo M, et al. Among authors: arpa j. Ann Neurol. 2014 Oct;76(4):509-21. doi: 10.1002/ana.24248. Epub 2014 Aug 30. Ann Neurol. 2014. PMID: 25112865 Clinical Trial.
Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.
Reetz K, Dogan I, Costa AS, Dafotakis M, Fedosov K, Giunti P, Parkinson MH, Sweeney MG, Mariotti C, Panzeri M, Nanetti L, Arpa J, Sanz-Gallego I, Durr A, Charles P, Boesch S, Nachbauer W, Klopstock T, Karin I, Depondt C, vom Hagen JM, Schöls L, Giordano IA, Klockgether T, Bürk K, Pandolfo M, Schulz JB. Reetz K, et al. Among authors: arpa j. Lancet Neurol. 2015 Feb;14(2):174-82. doi: 10.1016/S1474-4422(14)70321-7. Epub 2015 Jan 5. Lancet Neurol. 2015. PMID: 25566998 Clinical Trial.
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA).
Reetz K, Hilgers RD, Isfort S, Dohmen M, Didszun C, Fedosov K, Kistermann J, Mariotti C, Durr A, Boesch S, Klopstock T, Rodríguez de Rivera Garrido FJ, Schöls L, Klockgether T, Pandolfo M, Korinthenberg R, Lavin P, Molenberghs G, Libri V, Giunti P, Festenstein R, Schulz JB; EFACTS or NICOFA study group. Reetz K, et al. Neurol Res Pract. 2019 Oct 15;1:33. doi: 10.1186/s42466-019-0038-9. eCollection 2019. Neurol Res Pract. 2019. PMID: 33324899 Free PMC article. Clinical Trial.
Ophthalmic features of Friedreich ataxia.
Noval S, Contreras I, Sanz-Gallego I, Manrique RK, Arpa J. Noval S, et al. Among authors: arpa j. Eye (Lond). 2012 Feb;26(2):315-20. doi: 10.1038/eye.2011.291. Epub 2011 Nov 18. Eye (Lond). 2012. PMID: 22094302 Free PMC article.
90 results